MedKoo Cat#: 123053 | Name: Wee1-IN-5
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

WEE1-IN-5 (Debio 0123) is a potent Wee1 inhibitor that inhibits phospho-CDC2 and abrogates the G2 check point.

Chemical Structure

Wee1-IN-5
Wee1-IN-5
CAS#2243882-74-6 (free base)

Theoretical Analysis

MedKoo Cat#: 123053

Name: Wee1-IN-5

CAS#: 2243882-74-6 (free base)

Chemical Formula: C26H28Cl2N6O

Exact Mass: 510.1700

Molecular Weight: 511.45

Elemental Analysis: C, 61.06; H, 5.52; Cl, 13.86; N, 16.43; O, 3.13

Price and Availability

Size Price Availability Quantity
5mg USD 650.00 2 Weeks
25mg USD 1,550.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
Wee1-IN-5; Debio 0123; 2243882-74-6; SCHEMBL23298351; EX-A5145; HY-147054; Debio-0123; Zedoresertib
IUPAC/Chemical Name
3-(2,6-dichlorophenyl)-1-methyl-7-((3-methyl-4-(1-methylpiperidin-4-yl)phenyl)amino)-2,3-dihydropyrimido[4,5-d]pyrimidin-4(1H)-one
InChi Key
VWHNEYAANMETIA-UHFFFAOYSA-N
InChi Code
InChI=1S/C26H28Cl2N6O/c1-16-13-18(7-8-19(16)17-9-11-32(2)12-10-17)30-26-29-14-20-24(31-26)33(3)15-34(25(20)35)23-21(27)5-4-6-22(23)28/h4-8,13-14,17H,9-12,15H2,1-3H3,(H,29,30,31)
SMILES Code
CC1=C(C=CC(=C1)NC2=NC=C3C(=N2)N(CN(C3=O)C4=C(C=CC=C4Cl)Cl)C)C5CCN(CC5)C
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 511.45 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Matheson CJ, Backos DS, Reigan P. Targeting WEE1 Kinase in Cancer. Trends Pharmacol Sci. 2016 Oct;37(10):872-881. doi: 10.1016/j.tips.2016.06.006. Epub 2016 Jul 14. PMID: 27427153. 2: Kong A, Mehanna H. WEE1 Inhibitor: Clinical Development. Curr Oncol Rep. 2021 Jul 16;23(9):107. doi: 10.1007/s11912-021-01098-8. PMID: 34269904; PMCID: PMC8285350. 3: Ghelli Luserna di Rorà A, Cerchione C, Martinelli G, Simonetti G. A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target. J Hematol Oncol. 2020 Sep 21;13(1):126. doi: 10.1186/s13045-020-00959-2. PMID: 32958072; PMCID: PMC7507691. 4: Koh SB. The expanding role of WEE1. Cell Signal. 2022 Jun;94:110310. doi: 10.1016/j.cellsig.2022.110310. Epub 2022 Mar 16. PMID: 35304285. 5: Shi L, Xue X, Tian H, Ye H, Wang H, Wang R, Liu Y, Zhang C, Chen Q, Sun L. WEE1 promotes endometriosis via the Wnt/β-catenin signaling pathway. Reprod Biol Endocrinol. 2021 Oct 22;19(1):161. doi: 10.1186/s12958-021-00844-8. PMID: 34686198; PMCID: PMC8532311.